HCC
AGN

Hirtle Callaghan & Co’s Allergan Inc AGN Stock Holding History

Hirtle Callaghan & Co’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-8,217
Closed -$1.75M – 512
2014
Q4 		$1.75M Hold
8,217
– – 0.4% 41
2014
Q3 		$1.46M Hold
8,217
– – 0.24% 54
2014
Q2 		$1.39M Hold
8,217
– – 0.19% 71
2014
Q1 		$1.02M Hold
8,217
– – 0.17% 76
2013
Q4 		$913K Sell
8,217
-10
-0.1% -$955 0.12% 90
2013
Q3 		$744K Buy
+8,227
New +$739K 0.12% 100

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Hirtle Callaghan & Co's AGN Position: Q1 2015 in Review

Hirtle Callaghan & Co sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 8,217 shares — an estimated $1.75M sold.

Hirtle Callaghan & Co first reported a position in AGN in Q3 2013 and held it in 6 quarters. The position peaked at $1.75M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Hirtle Callaghan & Co reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Hirtle Callaghan & Co sold 8,217 Allergan Inc shares in Q1 2015, an estimated $1.75M.
  • Hirtle Callaghan & Co first reported a position in Allergan Inc in Q3 2013 and held it in 6 quarters.
  • Hirtle Callaghan & Co's Allergan Inc position peaked at $1.75M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Hirtle Callaghan & Co's 13F filing for Q1 2015, filed 15 May 2015.